In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging
- 281 Downloads
Aptamers have become the most promising recognition reagents in terms of early diagnosis and effective treatment of cancers. In this study, using cervical cancer as a model, we have identified a DNA aptamer specifically binding to cervical cancer cells with high affinity using the cell-SELEX (systematic evolution of ligands by exponential enrichment) method, in which a negative selection was carried out using normal epithelial cells as control. The binding abilities of 6 selected truncated aptamers were determined by laser confocal fluorescence microscopy and flow cytometry, while most of them only recognize the target cells and do not bind the control cells, and the aptamer C-9S with 51-mer shows the best binding affinity to Ca Ski cells (target cells) with a dissociation constant value of 19.3 ± 2.9 nM. Moreover, at physiological temperature, C-9S remains its specific recognition capability to Ca Ski cells as well. Meanwhile, C-9S shows a similar binding ability to another cervical cancer cells (HeLa). Therefore, on the basis of its excellent targeting properties and inherent functional versatility of aptamer, C-9S holds great potential to be a molecular probe for early detection, in vivo imaging, and targeted delivery for further researches in cancer.
KeywordsAptamer Cell-SELEX Molecular probe Cervical cancer
The authors would like to thank the National Natural Science Foundation of China (Nos. 21775160, 21575154), the International Partnership Program of Chinese Academy of Sciences (No. 121E32KYSB20170025), the Science Foundation of Jiangsu Province (Nos. BE2016680, BK20161262, BE2018665, EK20180250), and the Jiangsu Province Six Talent Peaks program for financial support.
- Esposito CL, Catuogno S, de Franciscis V, Cerchia L (2011) New insight into clinical development of nucleic acid aptamers. Discov Med 11:487–496Google Scholar
- Ferrandina G, Macchia G, Legge F, Deodatod F, Fornib F, Digesud C, Caronec V, Morgantid AG, Scambia G (2008) Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome. Oncology 74:42–49CrossRefGoogle Scholar
- Grubisic G (2007) Limitations of colposcopy in early invasive cervical cancer detection. Coll Antropol 31:135–138Google Scholar
- Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628–1650Google Scholar
- Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M, Schwartz LH, Woodward P, Pannu H, Hricak H (2006) Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 24:5687–5694CrossRefGoogle Scholar
- Shi Y, Zhang J, He J, Liu D, Meng X, Huang T, He H (2019) A method of detecting two tumor markers (p-hydroxybenzoic acid and pcresol) in human urine using a porous magnetic β-cyclodextrine polymer as solid phase extractant, an alternative for early gastric cancer diagnosis. Talanta 191: 133–140.CrossRefGoogle Scholar